Estimating the time since infection (TI) in newly diagnosed HIV-1 patients is challenging, but important to understand the epidemiology of the infection. Here we explore the utility of virus diversity estimated by next-generation sequencing (NGS) as novel biomarker by using a recent genome-wide longitudinal dataset obtained from 11 untreated HIV-1-infected patients with known dates of infection. The results were validated on a second dataset from 31 patients.
If possible information from several methods to determine TI were combined. The 81 true TIs were considered to be without measurement error. Comprehensive information 82 is provided in the S6 Table and the S7 Table. 83 CD4 counts, virus levels and BED tests 84 Plasma HIV-1 RNA levels were measured using the Cobas AmpliPrep sample 85 preparation system followed by analysis using the Cobas Amplicor HIV-1 monitor 86 version 1.5 or the Cobas TaqMan HIV-1 v1.0 or v2.0 (Roche Molecular Systems, Basel, 87 Switzerland). CD4+ T-lymphocyte (CD4) cells were enumerated using flow cytometry. 88 As part of determination of the true TIs, BED testing was performed on the first 89 plasma sample from each study subject using the Aware BED EIA HIV-1 Incidence 90 Test (Calypte Biomedical Corporation, Portland, OR, USA) according to the 91 manufacturer's instructions.
92
HIV-1 RNA sequences 93 Whole-genome deep-sequencing of virus RNA populations in plasma samples obtained 94 before start of therapy was performed as previously described [24, 32] . In short, total 95 RNA in plasma was extracted using RNeasy Lipid Tissue Mini Kit (Qiagen Cat No. Sequencing reads are available in the European Nucleotide Archive under accession 103 number PRJEB9618 and processed data are available at hiv.biozentrum.unibas.ch. 104 The samples of the validation dataset were sequenced and processed using the same 105 protocol and analysis pipeline [24, 32] . Patient-specific consensus sequences were 106 constructed using an iterative mapping procedure. All reads were then remapped 107 against this reference to calculate iSNV frequencies (i.e. pile-ups or tables how often 108 each nucleotide was observed at every position of the genome). Sequencing and 109 mapping/assembly was successful for 56 of the 62 samples. Filtered short-reads were 110 submitted to ENA and are available under study accession number PRJEB21629. iSNV 111 frequency counts at each position of pol and gag are available as part of the analysis 112 code repository at github.com/neherlab/HIV_time_of_infection. 113 All analyses were done in Python using the libraries numpy, biopython, and 114 matplotlib [33] [34] [35] . These iSNV frequency tables were then used to calculate average 115 pairwise distances, average alignment entropies, or the number of sites with variation 116 above a cutoff x c . 117 Statistical procedures 118 We have used three different diversity measures: fraction of polymorphic sites, average 119 pairwise distance per length, and site entropy. All of these measures can be 120 straight-forwardly calculated from the frequencies of different nucleotides x iα at site 121 i = 1 . . . L and α ∈ {A, C, G, T} along the genome. Prior to calculation the nucleotide 122 frequencies for each site were normalized to sum to unity (i.e. ignoring gaps or positions 123 not called by the sequencer.)
124
For all methods, we introduce a cutoff x c . Sites at which the sum of all minor 125 variants is smaller than x c contribute zero to the diversity measure. This cutoff serves 126 to filter sequencing errors or rare variation that cannot be reproducibly measured across 127 PLOS 4/21 samples. When using the fraction of polymorphic sites as diversity measure, x c serves as 128 the value above which sites are considered "polymorphic". Specifically, the fraction of 129 polymorphic sites is defined as
where x m i is the frequency of the dominant nucleotide at position i, and Θ(x) is 1 when 131 x > 0 and 0 otherwise (i.e. Θ(1 − x m i − x c ) = 1 when 1 − x m i > x c and 0 otherwise). D A 132 is thus the fraction of sites at which the dominant nucleotide is less frequent than 1 − x c . 133 The average pairwise distance is the probability that two randomly drawn sequences 134 have different nucleotides at a specified position, averaged over all positions. It can be 135 calculated from the x iα as
The quantity defined by Eq. (2) is the conventional Nei-Li nucleotide diversity [36] 137 ( α x iα (1 − x iα )) averaged over the sites. We refer to it as "average pairwise distance" 138 whenever it is necessary to distinguish it from the other diversity measures introduced 139 here, but otherwise call it simply "diversity".
140
This diversity measure is similar to the fraction of polymorphic sites with the 141 important difference that the contribution of each site is weighted by a frequency 142 dependent factor.
143
The average site entropy is defined by
and differs from the average pairwise distance by the weighing function used. The 145 entropy puts more weight on sites with rare variation. This can increase the information 146 of the measure about TI, but can also be detrimental if too much weight is put on 147 frequencies dominated by sequencing error. We evaluate and discuss the merits of the 148 different measures below. We use the average pairwise distance as default diversity 149 measure.
150
Given a diversity measure D, we model TI by
where s is the conversion factor between diversity and time, and t 0 is the intercept value 152 intended to accommodate possible non-linearity of diversity at small times.
153
To estimate values of s, t 0 we minimized the average prediction error for the 154 available data points in respect to these two parameters (see S1 Appendix for more 155 details) The error in estimating s, t 0 was calculated by randomly sampling the patients 156 (bootstrapping over the patients).
157

Cross-validation 158
To test the accuracy of the TI inference we used ten of the eleven patients as training 159 data (to determine the slope and the intercept) treating the eleventh patient as test 160 data. This procedure was repeated for every patient. Leaving out one patient at a time, 161 rather than one sample at a time, gives more accurate confidence intervals as different 162 samples from the same patients are correlated. We included in statistical analysis only 163 refer to this estimate as the estimated time since infection (ETI).
179
To validate the findings we used a second dataset consisting of similar sequence data 180 from 31 additional patients (two samples per patient). The patient characteristics in 181 validation dataset was more diverse than for the 11 patients training dataset. Thus, 16 182 of the 31 patients were infected with non-B-subtypes of HIV-1 and 11 patients belonged 183 to other transmission groups than MSM. See methods and (S7 Table) .
184
Sequence diversity as a biomarker 185 All three diversity measures described in Materials and Methods grew linearly with time 186 in the eleven patients. Fig. 1 shows average pairwise distance in the pol separately for 187 each codon position. Most diversity in pol is synonymous and accumulates at 3rd codon 188 positions, while diversity at 1st and 2nd codon positions remained low throughout. This 189 pattern was less pronounced in other genes [24, 37] (see also S1 Fig and S2 Fig) . In env, 190 in particular, frequent selective sweeps result in a saturation of diversity later in 191 infection [17, 24] . 192 We quantified the fraction of variation in diversity measures that could be explained 193 by a linear regression of sample date vs. diversity using the coefficient of determination 194 (r 2 ), see the S3 available, a linear regression explained between 70% and 90% of variation if rare iSNVs 196 below 20% population frequency were included, that is the cutoff x c was below 0.2. The 197 coefficient of determination was much smaller when only iSNVs between 20% and 80% 198 were included, that is the x c cutoff is larger than 0.2. This decrease is due to increased 199 noise as fewer and fewer sites contribute to the diversity measures. mutations are mostly synonymous) exhibited higher r 2 , whereas the trajectories at the 202 1st and 2nd codon positions saturated quickly after the infection, Fig. 1 . Thus, in the 203 following we limit the analysis mainly to sites in 3rd codon positions (whenever we are 204 dealing with a whole gene, i.e. when the reading frame is known.) However, the results 205 reported below show that inclusion of 1st and 2nd codon positions only has a small 206 deleterious effect on the accuracy of the TI estimates. less deeply in our dataset (again env, see [24] ).
220
The precision of the TI estimates obtained for windows corresponding to particular 221 genes are shown in Fig. 2 x c = 0.003, which represents the cutoff for sequencing errors for our NGS method [24] . 252 The noticeably non-monotonic behavior of the predictions based on average pairwise 253 these sites saturates at different levels [37] . As the threshold x c is lowered, sites with 258 higher and higher fitness costs contribute to the diversity measures and the effect of the 259 saturation behavior becomes more pronounced. Note that the non-monotonic In the following analyses we opted for using the average pairwise distance measure, 265 taking into account only the diversity at the 3rd codon positions, with low (x c = 0.003) 266 iSNV cutoff. Average pairwise distance was chosen because the results were virtually 267 indistinguishable from those produced using site entropy, but easier to calculate and 268 interpret. Since 1st and 2nd codon positions contribute very little time-dependent 269 diversity and are affected by purifying selection and selective sweeps, we recommend to 270 restrict the diversity measures to 3rd codon positions.
271
Distribution of prediction errors 272
The results above indicated that more than 50% of the estimated TIs fell within a 273 window of about one year centered at the actual TI. Fig. 4 (Left) shows a more direct 274 analysis of the distribution of TI prediction errors. The distribution is tightly peaked 275 around zero, but has a left tail corresponding to samples estimated to have been 276 obtained shorter after infection than they actually were drawn, i.e. diversity being lower 277 than expected. Most of these samples were from p6, who throughout infection had lower 278 diversity than other patients. In addition to biological reasons for low diversity, Some samples were estimated to have been drawn later after infection than the true 282 duration of infection. In particular early samples from p10 and p3 had markedly higher 283 diversity than expected. For both patients, we have evidence that their infections were 284 established by more than one virion resulting in carry-over of diversity from the donor. 285 This excess diversity gradually decreased in p10 and, somewhat slower, in p3.
286
Next, we investigated how the prediction error depended on the time since infection. 287 Fig. 5 shows the average absolute error of the estimated TI versus the true TI, averaged 288 over n = 25 consecutive data points. This average error (see for details S2 Appendix) 289 was surprisingly stable over TIs, and only increased slightly from around 0.6 years to 290 around 1.1 years as the age of infection increased from 6 months to 6 years. This 291 increase can be attributed to bigger statistical fluctuations of diversity later after 292 infection due to factors such as variations in the rate of diversification or differences in 293 number and strength of selective sweeps that reduce diversity.
294
Recommended regression coefficients 295 In Table 2 we list the values of slope and intercept that can be used to estimate the 296 infection date from the known diversity calculated as average pairwise distances for 3rd 297 codon positions in pol gene. The supplementary materials contain similar tables for the 298 two other diversity measures (S1 Table and S2 Table) , as well as for the case when all 299 codon positions are taken into account (S3 Table, S4 Table and S5 Table) . As the iSNV 300 resolution may vary between different sequencing methods and facilities, we list the 301 values of the parameters for different cutoffs, implying that all the frequencies below the 302 cutoff value are set to zero and the corresponding sites do not contribute to the 303 diversity measure. Note that the slope (and intercept) increases with increasing iSNV 304 cutoffs because fewer and fewer sites contribute to diversity. In addition to the two 305 parameter model, we also investigated the performance of a model with the slope as the 306 single parameter, i.e. no intercept (t 0 = 0). This model has a slightly higher absolute 307 prediction error. However, for low values of the cutoff x c ≈ 5% these models agree and 308 for cutoffs below 20% the two models perform equally well. 
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In order to make our data and the method of TI inference more accessible for 310 practical use, we added a web application to the web site containing the processed 311 patient data, accessible at hiv.biozentrum.unibas.ch/ETI/. Given a diversity value 312 (determined according to Eq. (2)), the web application allows to determine the time 313 since infection for an user-selected iSNV cutoff value (x c ) and genetic region, along with 314 the appropriate error estimates. The results are presented in accessible graphical form, 315 but also as a slope and intercept pair, equivalent to Table. 2. The user can specify 316 whether the diversity was calculated using all codon positions or only the 1st, 2nd, or 317 3rd. Specifying a codon position is only supported when the region used to evaluate 318 diversity is fully contained in one gene.
319
Validation of the regression coefficients 320 We validated the regression coefficients on a dataset from 31 patients with known 321 infection dates and NGS data available at two time points. The distribution of the 322 diversity values for these patients closely resembles that for our training dataset of 11 323 patients (see S8 Fig and S9 Fig) . 324 We inferred the time since infection for the 31 validation patients using the 325 regression coefficients obtained for the eleven patients of the training set; the results are 326 summarized in Fig. 6 , which also shows (in gray) the data points of the training set 327 (same as in Fig. 4 ). The new data exhibit the same behavior as the training set: the TI 328 estimates are centered around the true TI and the accuracy of the estimate is about one 329 year, as can be seen from the histogram in the left panel of Fig. 6 . In order to make the 330 histograms for the training and validation data comparable, we included for the former 331 only the points of the infection time less than 5 years.
332
Some outliers are present also in validation data, particularly data points with 333 overestimated TIs, i.e. having higher diversity than expected. As mentioned above, 334 these data points probably often represent infections established by more than one 335 founder virus. One patient had substantial overestimation of time since infection, which 336 might be due to superinfection from different donors rather than multiple founders from 337 a single donor. However, it should be stressed that almost all outliers are still within 338 +/-2 years from the true TI. Neither overestimation nor underestimation of TI was 339 PLOS 11/21 clearly related to genetic subtype of the virus, transmission route, virus levels or 340 template numbers (S11 Fig and S12 Fig) . Many newly diagnosed HIV-1 patients have an infection of unknown duration. This is 343 problematic because accurate estimation of the time since infection (TI) is essential for 344 understanding important aspects of HIV-1 epidemiology such as incidence, proportion 345 of undiagnosed patients and late presentation. Most previous methods are suboptimal 346 because they only categorize patients as being recently or long-term infected and/or are 347 imprecise. Here, we show that genetic diversity calculated from NGS data enables fairly 348 accurate estimation of TI, even many years after infection. We also show that NGS is 349 superior to Sanger sequencing because inclusion of minority iSNVs below the Sanger 350 detection limit (around 25%) substantially improves the accuracy of the TI estimates. 351 We investigated how the TI estimates were influenced by sequence length, genome year of infection. The env gene was less suitable than pol for estimating TI, especially if 359 longer time had elapsed since infection. This is because frequent selective sweeps in env 360 continuously remove diversity and this effect becomes increasingly evident with 361 increasing time since infection [17, 24] . This explains why the most accurate results were 362 obtained using 2000-3000 base pair long sequences covering pol, while omitting env. We 363 found that most of temporal signal came from 3rd codon positions (at which most 364 mutations are synonymous) and that omission of 1st and 2nd codon positions slightly 365 improved TI estimates for iSNV cutoffs (x c ) below 10%, i.e. when the full potential of 366 NGS was utilized. Diversity measures based on average pairwise distance and site 367 entropy outperformed the measure based on fraction of polymorphic sites at low iSNV 368 cutoffs.
369
Based on our results we make the following recommendations for TI estimation based 370 on HIV NGS data; average pairwise distance on 3rd codon positions in pol sequences 371 with the lowest possible cutoff for iSNVs (in our case 0.3%). Importantly, we have 372 validated our recommendations by applying them to a validation dataset consisting of 373 NGS data from 31 additional patients with known infection times. The accuracy of TI 374 estimation for the validation data was as accurate and precise as for the training data, 375 which confirms the applicability of our method for broader clinical and epidemiological 376 use. For convenience we provide a table that translates viral diversity into TI as well as 377 a web application that estimates TI for user-defined regions of the HIV-1 genome.
378
Even though we primarily have focused on estimation of TI in individual patients, 379 our method can be applied to estimation of incidence in populations. Many methods for 380 HIV-1 incidence estimation in populations have been based on biomarkers that classify 381 patients as recently or long-term infected (e.g. the BED and LAg assays). [1] [2] [3] [4] [5] [6] [7] . Such 382 binary classification can be done based on NGS data; if the diversity is less than a 383 specified cutoff value D cr infection is classified as recent, and otherwise as long-term.
384
The cutoff between recent and long-term infections can be chosen by the investigator 385 using Table 2 or the website. For instance a diversity of 0.0021 for 3rd bases on pol 386 corresponds to 180 days since infection. However, we have not fully determined two test 387 properties that are required for most binary incidence estimators; the mean duration of 388 recent infection (MDRI) and the false-recent rate (FRR) [38] . The NGS data can also 389 be used to directly model HIV-1 incidence based on TIs [39, 40] .
390
Our study has some limitations. Ideally we should have studied a larger and more and non-MSM as well as subtype B and non-B infections, which again suggests that our 402 regression coefficients can be broadly applied (S11 Fig and S12 Fig) . 403 Another limitation is that the true (i.e. "known") TI was estimated from laboratory 404 and clinical data and therefore has an error that we have not considered because it is 405 difficult to estimate. However, such a measurement error, which surely exists, will 406 reduce the accuracy at which TI can be estimated and assuming zero measurement 407 error for the "true" TI is therefore conservative.
408
A potential problem with NGS data is incomplete sampling of virus diversity in 409 samples with low virus levels. If the sequencing library is dominated by a few template 410 molecules the TI estimate might be erroneously short. A related problem is due to the 411 reduced ability of NGS to correctly estimate TI in infections that were founded by 412 multiple virions. Two of our 11 training patients showed evidence of such multiple 413 infections. Clear overestimation of TI was also observed in one of the 31 validation 414 patients. It has been reported that HIV-1 infection is founded by more than one virion 415 in around 40% of MSM and around 20% of heterosexuals, whereas superinfection (from 416 different donors) is more rare [41, 42] . In view of the fact that most of our study 417 patients were MSM, it is surprising that serious overestimation of TI was not observed 418 more often. There are two possible explanations for this. Firstly, TI will only be 419 overestimated if the multiple founders are sufficiently diverse. Secondly, the 420 overestimation of TI appeared to diminished over time in the two training patients, 421 which may happen if excess diversity is removed because favored iSNVs are selected for 422 over time [24] . Even though our method has limitations with multiple founders and 423 superinfection, a diversity value that exceeds the upper 95% confidence value of the 424 diversity that expected 10 years or more after infection should be treated with great 425 caution, because it may be due to multiple founders and/or superinfection. 426 Furthermore, we plan to investigate estimation of TI can be improved by combining 427 virus diversity determined NGS with other biomarkers, such as BED, LAg avidity, CD4 428 and virus levels, in a multiple assay algorithm. 429 Finally, NGS is not yet part of routine diagnostics for HIV resistance. However, in 430 the coming years NGS can be expected to replace Sanger sequencing for clinical HIV-1 431 resistance testing, which is recommended for all newly diagnosed patients (in developed 432 countries). Thus, while our method for estimating TI from NGS data currently requires 433 extra laboratory work, NGS data is likely to become increasingly available as part of 434 routine HIV-1 care, which will increase the utility of our method.
435
Conclusion
436
In conclusion, we show that sequence diversity determined by NGS can be used to 437 estimate time since HIV-1 infection with a precision that is better than most alternative 438 biomarkers. Importantly, TI can be estimated many years after infection, whereas most 439 alternative methods only categorize patients as being recently or long-term infected or 440 are less precise. We found that TI was most accurately estimated using 3rd codon 441 positions in pol sequences with a x c = 0.003 cutoff for iSNVs and that average pairwise 442 distances was the preferred distance measure. Samples with low virus levels and 509 S1 Text Supporting text for S6 Table. 510 Table 1 . Summary of patient characteristics. PLOS 20/21 
